These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Relapse prevention and recovery in the treatment of schizophrenia. Schooler NR. J Clin Psychiatry; 2006 Apr; 67 Suppl 5():19-23. PubMed ID: 16822093 [Abstract] [Full Text] [Related]
4. The efficacy of antipsychotic drugs and family therapies in the maintenance treatment of schizophrenia. Schooler NR. J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):11S-19S. PubMed ID: 2870086 [Abstract] [Full Text] [Related]
6. Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies. Kane JM. J Clin Psychiatry; 2003 Feb; 64 Suppl 16():34-40. PubMed ID: 14680417 [Abstract] [Full Text] [Related]
7. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses. Turner MS, Stewart DW. J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985 [Abstract] [Full Text] [Related]
8. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia. Gaebel W, Möller HJ, Buchkremer G, Ohmann C, Riesbeck M, Wölwer W, Von Wilmsdorff M, Bottlender R, Klingberg S. Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342 [Abstract] [Full Text] [Related]
14. Strategies for the long-term treatment of schizophrenia: real-world lessons from the CATIE trial. Meyer JM. J Clin Psychiatry; 2007 Apr; 68 Suppl 1():28-33. PubMed ID: 17286525 [Abstract] [Full Text] [Related]
15. Mental health practitioner's attitude towards maintenance neuroleptic treatment for people with schizophrenia. Harris N, Lovell K, Day JC. J Psychiatr Ment Health Nurs; 2007 Apr; 14(2):113-9. PubMed ID: 17352772 [Abstract] [Full Text] [Related]
17. [Influence of treatment course on the success of psychopharmacotherapy]. Gaebel W. Psychiatr Prax; 1985 Jan; 12(1):13-8. PubMed ID: 2858897 [Abstract] [Full Text] [Related]
18. Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment. Altamura AC, Bobo WV, Meltzer HY. Int Clin Psychopharmacol; 2007 Sep; 22(5):249-67. PubMed ID: 17690594 [Abstract] [Full Text] [Related]
19. Optimisation of long-term treatment in schizophrenia: treating the true spectrum of symptoms. Kasper S. Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S135-41. PubMed ID: 16872809 [Abstract] [Full Text] [Related]
20. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia. Loosbrock DL, Zhao Z, Johnstone BM, Morris LS. J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539 [Abstract] [Full Text] [Related] Page: [Next] [New Search]